Leaflet TRECID 100mg / 5ml syrup

Product code:
W61759001
Quantity:
1
Indicated for:
respiratory disorders with viscous secretions
Route of administration:
oral
Substance:
carbocisteine (mucolytic)
ATC
R05CB03 — Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Carbocisteine is a mucolytic agent used to thin and loosen thick, viscous mucus in the airways, making it easier to expel. It is indicated for the treatment of respiratory conditions such as chronic bronchitis, sinusitis, or other obstructive lung diseases.

Carbocisteine works by reducing mucus viscosity, helping to relieve productive cough and improve breathing. It is available in syrup or capsule form and can be administered to both adults and children, depending on the recommended dosage.

Side effects are rare but may include nausea, stomach discomfort, or allergic reactions. It is contraindicated in cases of active gastric ulcers or hypersensitivity to the substance.

General data about TRECID 100mg / 5ml

Substance:
carbocisteine
Date of latest medicines list:
01-07-2020
Product code:
W61759001
Concentration:
100mg / 5ml
Pharmaceutical form:
syrup
Quantity:
1
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
BIOFARM S.A. - ROMANIA
Holder:
BIOFARM S.A. - ROMANIA
Number:
13064/2020/01
Shelf life:
1 year-after packing for marketing;after the first opening of the bottle-20 days

Pharmaceutical forms available for carbocisteine

Concentrations available for carbocisteine

  • 100mg/5ml
  • 2%
  • 20mg/ml
  • 250mg/5ml
  • 300mg
  • 5%
  • 50mg/ml
  • 750mg/15ml
  • 9%